The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Terbinafine Hydrochloride Drug-Global Market Insights and Sales Trends 2025

Terbinafine Hydrochloride Drug-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1808650

No of Pages : 116

Ask Your Query
Synopsis
Terbinafine, sold under the brand name Lamisil among others, an antifungal medication used to treat pityriasis versicolor, fungal nail infections, and ringworm including jock itch and athlete's foot. It is either taken by mouth or applied to the skin as a cream or ointment. The cream and ointment are not effective for nail infections.
The global Terbinafine Hydrochloride Drug market size is expected to reach US$ 912.6 million by 2029, growing at a CAGR of 6.4% from 2023 to 2029. The market is mainly driven by the significant applications of Terbinafine Hydrochloride Drug in various end use industries. The expanding demands from the Fingernail Infection, Toenail Infection and Others,, are propelling Terbinafine Hydrochloride Drug market. Topical, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Oral segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Terbinafine Hydrochloride Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Terbinafine Hydrochloride Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Terbinafine Hydrochloride Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Terbinafine Hydrochloride Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Terbinafine Hydrochloride Drug covered in this report include Novartis, GSK, TEVA, Dr. Reddy's Laboratories, CIPLA LTD, TARO, InvaGen Pharmaceuticals, Breckenridge Pharmaceutical and Harris Pharmaceutical, etc.
The global Terbinafine Hydrochloride Drug market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
GSK
TEVA
Dr. Reddy's Laboratories
CIPLA LTD
TARO
InvaGen Pharmaceuticals
Breckenridge Pharmaceutical
Harris Pharmaceutical
Glenmark
Orchid Healthcare
APOTEX
Jilin Wantong Group
Cussess
Hubei Hengan Fulin Pharm
Xiuzheng Pharmaceutical
Global Terbinafine Hydrochloride Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Terbinafine Hydrochloride Drug market, Segment by Type:
Topical
Oral
Global Terbinafine Hydrochloride Drug market, by Application
Fingernail Infection
Toenail Infection
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Terbinafine Hydrochloride Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Terbinafine Hydrochloride Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Terbinafine Hydrochloride Drug Market Overview
1.1 Terbinafine Hydrochloride Drug Product Overview
1.2 Terbinafine Hydrochloride Drug Market Segment by Type
1.2.1 Topical
1.2.2 Oral
1.3 Global Terbinafine Hydrochloride Drug Market Size by Type
1.3.1 Global Terbinafine Hydrochloride Drug Market Size Overview by Type (2018-2029)
1.3.2 Global Terbinafine Hydrochloride Drug Historic Market Size Review by Type (2018-2023)
1.3.3 Global Terbinafine Hydrochloride Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Terbinafine Hydrochloride Drug Sales Breakdown by Type (2018-2023)
1.4.2 Europe Terbinafine Hydrochloride Drug Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Terbinafine Hydrochloride Drug Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Terbinafine Hydrochloride Drug Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Terbinafine Hydrochloride Drug Sales Breakdown by Type (2018-2023)
2 Global Terbinafine Hydrochloride Drug Market Competition by Company
2.1 Global Top Players by Terbinafine Hydrochloride Drug Sales (2018-2023)
2.2 Global Top Players by Terbinafine Hydrochloride Drug Revenue (2018-2023)
2.3 Global Top Players by Terbinafine Hydrochloride Drug Price (2018-2023)
2.4 Global Top Manufacturers Terbinafine Hydrochloride Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Terbinafine Hydrochloride Drug Market Competitive Situation and Trends
2.5.1 Terbinafine Hydrochloride Drug Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Terbinafine Hydrochloride Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Terbinafine Hydrochloride Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Terbinafine Hydrochloride Drug Market
2.8 Key Manufacturers Terbinafine Hydrochloride Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Terbinafine Hydrochloride Drug Status and Outlook by Region
3.1 Global Terbinafine Hydrochloride Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Terbinafine Hydrochloride Drug Historic Market Size by Region
3.2.1 Global Terbinafine Hydrochloride Drug Sales in Volume by Region (2018-2023)
3.2.2 Global Terbinafine Hydrochloride Drug Sales in Value by Region (2018-2023)
3.2.3 Global Terbinafine Hydrochloride Drug Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Terbinafine Hydrochloride Drug Forecasted Market Size by Region
3.3.1 Global Terbinafine Hydrochloride Drug Sales in Volume by Region (2024-2029)
3.3.2 Global Terbinafine Hydrochloride Drug Sales in Value by Region (2024-2029)
3.3.3 Global Terbinafine Hydrochloride Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Terbinafine Hydrochloride Drug by Application
4.1 Terbinafine Hydrochloride Drug Market Segment by Application
4.1.1 Fingernail Infection
4.1.2 Toenail Infection
4.1.3 Others
4.2 Global Terbinafine Hydrochloride Drug Market Size by Application
4.2.1 Global Terbinafine Hydrochloride Drug Market Size Overview by Application (2018-2029)
4.2.2 Global Terbinafine Hydrochloride Drug Historic Market Size Review by Application (2018-2023)
4.2.3 Global Terbinafine Hydrochloride Drug Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Terbinafine Hydrochloride Drug Sales Breakdown by Application (2018-2023)
4.3.2 Europe Terbinafine Hydrochloride Drug Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Terbinafine Hydrochloride Drug Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Terbinafine Hydrochloride Drug Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Terbinafine Hydrochloride Drug Sales Breakdown by Application (2018-2023)
5 North America Terbinafine Hydrochloride Drug by Country
5.1 North America Terbinafine Hydrochloride Drug Historic Market Size by Country
5.1.1 North America Terbinafine Hydrochloride Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Terbinafine Hydrochloride Drug Sales in Volume by Country (2018-2023)
5.1.3 North America Terbinafine Hydrochloride Drug Sales in Value by Country (2018-2023)
5.2 North America Terbinafine Hydrochloride Drug Forecasted Market Size by Country
5.2.1 North America Terbinafine Hydrochloride Drug Sales in Volume by Country (2024-2029)
5.2.2 North America Terbinafine Hydrochloride Drug Sales in Value by Country (2024-2029)
6 Europe Terbinafine Hydrochloride Drug by Country
6.1 Europe Terbinafine Hydrochloride Drug Historic Market Size by Country
6.1.1 Europe Terbinafine Hydrochloride Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Terbinafine Hydrochloride Drug Sales in Volume by Country (2018-2023)
6.1.3 Europe Terbinafine Hydrochloride Drug Sales in Value by Country (2018-2023)
6.2 Europe Terbinafine Hydrochloride Drug Forecasted Market Size by Country
6.2.1 Europe Terbinafine Hydrochloride Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe Terbinafine Hydrochloride Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific Terbinafine Hydrochloride Drug by Region
7.1 Asia-Pacific Terbinafine Hydrochloride Drug Historic Market Size by Region
7.1.1 Asia-Pacific Terbinafine Hydrochloride Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Terbinafine Hydrochloride Drug Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Terbinafine Hydrochloride Drug Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Terbinafine Hydrochloride Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Terbinafine Hydrochloride Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Terbinafine Hydrochloride Drug Sales in Value by Region (2024-2029)
8 Latin America Terbinafine Hydrochloride Drug by Country
8.1 Latin America Terbinafine Hydrochloride Drug Historic Market Size by Country
8.1.1 Latin America Terbinafine Hydrochloride Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Terbinafine Hydrochloride Drug Sales in Volume by Country (2018-2023)
8.1.3 Latin America Terbinafine Hydrochloride Drug Sales in Value by Country (2018-2023)
8.2 Latin America Terbinafine Hydrochloride Drug Forecasted Market Size by Country
8.2.1 Latin America Terbinafine Hydrochloride Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America Terbinafine Hydrochloride Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa Terbinafine Hydrochloride Drug by Country
9.1 Middle East and Africa Terbinafine Hydrochloride Drug Historic Market Size by Country
9.1.1 Middle East and Africa Terbinafine Hydrochloride Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Terbinafine Hydrochloride Drug Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Terbinafine Hydrochloride Drug Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Terbinafine Hydrochloride Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Terbinafine Hydrochloride Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Terbinafine Hydrochloride Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Novartis
10.1.1 Novartis Company Information
10.1.2 Novartis Introduction and Business Overview
10.1.3 Novartis Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Novartis Terbinafine Hydrochloride Drug Products Offered
10.1.5 Novartis Recent Development
10.2 GSK
10.2.1 GSK Company Information
10.2.2 GSK Introduction and Business Overview
10.2.3 GSK Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2018-2023)
10.2.4 GSK Terbinafine Hydrochloride Drug Products Offered
10.2.5 GSK Recent Development
10.3 TEVA
10.3.1 TEVA Company Information
10.3.2 TEVA Introduction and Business Overview
10.3.3 TEVA Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2018-2023)
10.3.4 TEVA Terbinafine Hydrochloride Drug Products Offered
10.3.5 TEVA Recent Development
10.4 Dr. Reddy's Laboratories
10.4.1 Dr. Reddy's Laboratories Company Information
10.4.2 Dr. Reddy's Laboratories Introduction and Business Overview
10.4.3 Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Products Offered
10.4.5 Dr. Reddy's Laboratories Recent Development
10.5 CIPLA LTD
10.5.1 CIPLA LTD Company Information
10.5.2 CIPLA LTD Introduction and Business Overview
10.5.3 CIPLA LTD Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2018-2023)
10.5.4 CIPLA LTD Terbinafine Hydrochloride Drug Products Offered
10.5.5 CIPLA LTD Recent Development
10.6 TARO
10.6.1 TARO Company Information
10.6.2 TARO Introduction and Business Overview
10.6.3 TARO Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2018-2023)
10.6.4 TARO Terbinafine Hydrochloride Drug Products Offered
10.6.5 TARO Recent Development
10.7 InvaGen Pharmaceuticals
10.7.1 InvaGen Pharmaceuticals Company Information
10.7.2 InvaGen Pharmaceuticals Introduction and Business Overview
10.7.3 InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2018-2023)
10.7.4 InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Products Offered
10.7.5 InvaGen Pharmaceuticals Recent Development
10.8 Breckenridge Pharmaceutical
10.8.1 Breckenridge Pharmaceutical Company Information
10.8.2 Breckenridge Pharmaceutical Introduction and Business Overview
10.8.3 Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Products Offered
10.8.5 Breckenridge Pharmaceutical Recent Development
10.9 Harris Pharmaceutical
10.9.1 Harris Pharmaceutical Company Information
10.9.2 Harris Pharmaceutical Introduction and Business Overview
10.9.3 Harris Pharmaceutical Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Harris Pharmaceutical Terbinafine Hydrochloride Drug Products Offered
10.9.5 Harris Pharmaceutical Recent Development
10.10 Glenmark
10.10.1 Glenmark Company Information
10.10.2 Glenmark Introduction and Business Overview
10.10.3 Glenmark Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Glenmark Terbinafine Hydrochloride Drug Products Offered
10.10.5 Glenmark Recent Development
10.11 Orchid Healthcare
10.11.1 Orchid Healthcare Company Information
10.11.2 Orchid Healthcare Introduction and Business Overview
10.11.3 Orchid Healthcare Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Orchid Healthcare Terbinafine Hydrochloride Drug Products Offered
10.11.5 Orchid Healthcare Recent Development
10.12 APOTEX
10.12.1 APOTEX Company Information
10.12.2 APOTEX Introduction and Business Overview
10.12.3 APOTEX Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2018-2023)
10.12.4 APOTEX Terbinafine Hydrochloride Drug Products Offered
10.12.5 APOTEX Recent Development
10.13 Jilin Wantong Group
10.13.1 Jilin Wantong Group Company Information
10.13.2 Jilin Wantong Group Introduction and Business Overview
10.13.3 Jilin Wantong Group Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Jilin Wantong Group Terbinafine Hydrochloride Drug Products Offered
10.13.5 Jilin Wantong Group Recent Development
10.14 Cussess
10.14.1 Cussess Company Information
10.14.2 Cussess Introduction and Business Overview
10.14.3 Cussess Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Cussess Terbinafine Hydrochloride Drug Products Offered
10.14.5 Cussess Recent Development
10.15 Hubei Hengan Fulin Pharm
10.15.1 Hubei Hengan Fulin Pharm Company Information
10.15.2 Hubei Hengan Fulin Pharm Introduction and Business Overview
10.15.3 Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Products Offered
10.15.5 Hubei Hengan Fulin Pharm Recent Development
10.16 Xiuzheng Pharmaceutical
10.16.1 Xiuzheng Pharmaceutical Company Information
10.16.2 Xiuzheng Pharmaceutical Introduction and Business Overview
10.16.3 Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Products Offered
10.16.5 Xiuzheng Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Terbinafine Hydrochloride Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Terbinafine Hydrochloride Drug Industrial Chain Analysis
11.4 Terbinafine Hydrochloride Drug Market Dynamics
11.4.1 Terbinafine Hydrochloride Drug Industry Trends
11.4.2 Terbinafine Hydrochloride Drug Market Drivers
11.4.3 Terbinafine Hydrochloride Drug Market Challenges
11.4.4 Terbinafine Hydrochloride Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Terbinafine Hydrochloride Drug Distributors
12.3 Terbinafine Hydrochloride Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock